Sequential and Combination Therapies of (223)RaCl(2) and Prostate-Specific Membrane Antigen Radioligand Therapy. Jadvar H. J Nucl Med 2023;64:1932-1933.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Jadvar H. Sequential and Combination Therapies of (223)RaCl(2) and Prostate-Specific Membrane Antigen Radioligand Therapy. J Nucl Med 2023;64:1932-1933.
PMID: 37827840